Stelvio presenting at Enzymes in Drug Discovery Summit on February 23, 2018 in San Diego

Alexey Terskikh, PhD, Chief Scientific Officer of Stelvio will be presenting in the track titled "Epigenetic Enzymes in Drug discovery" and in the session "Epigenetic Modification & Transcriptional Regulation." For more information, please visit the conference website: https://www.gtcbio.com/conferences/enzymes-drug-discovery-summit/?section=fullagenda

Stelvio Oncology Presenting at Indie Bio's Demo Day on September 14, 2017

I'm very excited to be presenting Stelvio Oncology at Indie Bio's Demo Day on September 14, 2017. I'll be on stage presenting with eleven other great biotechnology startup companies! 

Please see event details here: https://www.eventbrite.com/e/indiebio-sf-demo-day-sept-14th-2017-at-herbst-theater-tickets-35711180101

 

Stelvio Oncology featured in Popping the Bubbl

Great conversation with Pete Turner and Sandra Ponce de Leon bringing to light how we are discovering novel cancer therapeutics with our innovative technology.

http://www.poppingthebubbl.com/single-post/2017/08/18/Stelvio-Oncology-Takes-on-Cancer